ArticleFrontiers in oncology2025
Knowledge and attitudes toward human papillomavirus and cervical cancer prevention among women in the Asir Region, Saudi Arabia: a cross-sectional study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Knowledge and attitudes regarding cervical cancer among adult Kuwaiti women: A cross-sectional study.Scientific reports · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cervical cancer, mainly caused by Human Papillomavirus infection, is a growing public health concern in Saudi Arabia. Despite the availability of effective vaccination and screening programs in the country, awareness and acceptance remain limited, particularly among women in the Asir region. This study aimed to assess knowledge and attitudes toward Human Papillomavirus and cervical cancer prevention among women in the Asir region, Saudi Arabia. Methods: A cross-sectional study was conducted from January to March 2025 among women aged 18 and older in the Asir region of Saudi Arabia. A convenience sampling method was used to recruit participants. Data were collected through an online self-administered questionnaire, and multivariable logistic regression was performed to identify factors associated with knowledge and attitudes (p < 0.05). Results: Among the 523 participants, 66% demonstrated good knowledge of Human Papillomavirus and cervical cancer prevention, while 56% had positive attitudes. Awareness of Human Papillomavirus and the Human Papillomavirus vaccine was observed in 62.1% and 54% of women, respectively, while knowledge of screening tests remained limited at 32.7%. Only 21% of women reported being vaccinated against Human Papillomavirus. The main barriers discouraging women from practicing Pap tests were discomfort (65.4%) and lack of knowledge (63.7%). Factors significantly associated with lower odds of having good knowledge (Adjusted Odds Ratio, AOR) included older age (41-50 years: AOR = 0.479, 95% confidence interval (CI): 0.239-0.961; 51-60 years: AOR = 0.239, 95% CI: 0.113-0.505; >60 years: AOR = 0.127, 95% CI: 0.022-0.724), lower education (secondary school: AOR = 0.483, 95% CI: 0.305-0.764), and unmarried status (single: AOR = 0.562, 95% CI: 0.327-0.965; divorced/widowed: AOR = 0.413, 95% CI: 0.218-0.784). Negative attitudes were more prevalent among older women (41-50 years: AOR = 0.327, 95% CI: 0.170-0.629; 51-60 years: AOR = 0.272, 95% CI: 0.130-0.570; >60 years: AOR = 0.102, 95% CI: 0.012-0.876). Conclusion: The study demonstrated generally good knowledge and positive attitudes toward Human Papillomavirus vaccination and cervical cancer prevention among women in the Asir region; however, awareness of screening and vaccine uptake was suboptimal. Women who were older, less educated, or unmarried had lower knowledge and more negative attitudes. Targeted educational interventions through healthcare providers, school-based programs, and social media, along with improved healthcare access, are recommended to enhance awareness, encourage regular cervical cancer screening, and reduce disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.